Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway

Journal of Interferon and Cytokine Research

Volumn 34, Issue 3, 2014, Pages 195-203

  Yang, Songwei ^a   Yu, Min ^a   Sun, Lihua ^a   Yang, Hua ^a,b   Xiao, Weidong ^a   Yang, Xuechao ^a   Sun, Ligang ^a   Zhang, Chaojun ^a   Ma, Yuanhang ^a   Yang, Hanwenbo ^b   Liu, Yong ^a   Lu, Dingsong ^a   Teitelbaum, Daniel H ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TIGHT JUNCTION PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HYPOXIA; INTESTINAL EPITHELIAL BARRIER DYSFUNCTION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL LINE; ELECTRIC IMPEDANCE; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; I-KAPPA B KINASE; INFLAMMATION; INTERFERON-GAMMA; INTESTINAL MUCOSA; PROLINE; SIGNAL TRANSDUCTION; THIOCARBAMATES; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS; TRANSCRIPTION FACTOR RELA;

EID: 84895874831     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0044     Document Type: Article

References (59)

1. Al-Sadi RM, Ma TY. 2007. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 178(7):4641-4649
2. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, Fromm M. 2002. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115(Pt 24):4969-4976
3. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A. 2007. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18(12):4691-4697
4. Boivin MA, Roy PK, Bradley A, Kennedy JC, Rihani T, Ma TY. 2009. Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction. J Interferon Cytokine Res 29(1):45-54
5. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. 2003. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171(11):6164-6172
6. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. 2005. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19(8):923-933
7. Capaldo CT, Nusrat A. 2009. Cytokine regulation of tight junctions. Biochim Biophys Acta 1788(4):864-871
8. Chun YS, Yeo EJ, Choi E, Teng CM, Bae JM, Kim MS, Park JW. 2001. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 61(8):947-954
9. Dehne N, Brune B. 2009. HIF-1 in the inflammatory microenvironment. Exp Cell Res 315(11):1791-1797
10. Diraimondo TR, Klock C, Khosla C. 2012. Interferon-gamma activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: Implications for celiac sprue therapy. J Pharmacol Exp Ther 341(1):104-114
11. Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, Kannan KB, Sheth SU, Caputo FJ, Lu Q, Ramanathan M, Attan S, Badami CD, Doucet D, Barlos D, Bosch-Marce M, Semenza GL, Xu DZ. 2010. HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 299(4):G833-G843
12. Figueroa YG, Chan AK, Ibrahim R, Tang Y, Burow ME, Alam J, Scandurro AB, Beckman BS. 2002. NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Exp Hematol 30(12):1419-1427
13. Frede S, Freitag P, Otto T, Heilmaier C, Fandrey J. 2005. The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res 65(11):4690-4697
14. Furuse M, Furuse K, Sasaki H, Tsukita S. 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153(2):263-272
15. Gerber SA, Yatsula B, Maier CL, Sadler TJ, Whittaker LW, Pober JS. 2009. Interferon-gamma induces prolyl hydroxylase (PHD)3 through a STAT1-dependent mechanism in human endothelial cells. Arterioscler Thromb Vasc Biol 29(9):1363-1369
16. Gough DJ, Levy DE, Johnstone RW, Clarke CJ 2008. IFNgamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev 19(5-6):383-394
17. Groschwitz KR, Hogan SP. 2009. Intestinal barrier function: Molecular regulation and disease pathogenesis. J Allergy Clin Immunol 124(1):3-20; quiz 21-22
18. Gu L, Li N, Gong J, Li Q, Zhu W, Li J. 2011. Berberine ameliorates intestinal epithelial tight-junction damage and downregulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis 203(11):1602-1612
19. Guo S, Al-Sadi R, Said HM, Ma TY. 2013. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol 182(2):375-387
20. He F, Peng J, Deng XL, Yang LF, Camara AD, Omran A, Wang GL, Wu LW, Zhang CL, Yin F. 2012. Mechanisms of tumor necrosis factor-Alpha-induced leaks in intestine epithelial barrier. Cytokine 59(2):264-272
21. Hiraki M, Kitajima Y, Kai K, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K. 2012. Knockdown of hypoxiainducible factor-1alpha accelerates peritoneal dissemination via the upregulation of MMP-1 expression in gastric cancer cell lines. Exp Ther Med 4(3):355-362
22. Hot A, Zrioual S, Lenief V, Miossec P. 2012. IL-17 and tumour necrosis factor alpha combination induces a HIF-1alphadependent invasive phenotype in synoviocytes. Ann Rheum Dis 71(8):1393-1401
23. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. 2003. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting proteindependent nuclear factor kappa B activation. Biochem J 370(Pt 3):1011-1017
24. Juuti-Uusitalo K, Klunder LJ, Sjollema KA, Mackovicova K, Ohgaki R, Hoekstra D, Dekker J, van Ijzendoorn SC. 2011. Differential effects of TNF (TNFSF2) and IFN-gamma on intestinal epithelial cell morphogenesis and barrier function in three-dimensional culture. PLoS One 6(8):e22967
25. Kaelin WG, Jr., Ratcliffe PJ. 2008. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell 30(4):393-402
26. Kannan KB, Colorado I, Reino D, Palange D, Lu Q, Qin X, Abungu B, Watkins A, Caputo FJ, Xu DZ, Semenza GL, Deitch EA, Feinman R. 2011. Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 300(5):G853-G861
27. Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM. 1994. YC-1, a novel activator of platelet guanylate cyclase. Blood 84(12):4226-4233
28. Li SH, Shin DH, Chun YS, Lee MK, Kim MS, Park JW. 2008. A novel mode of action of YC-1 in HIF inhibition: Stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}. Mol Cancer Ther 7(12):3729-3738
29. Lin Y, Jamison S, Lin W. 2012. Interferon-gamma activates nuclear factor-kappa B in oligodendrocytes through a process mediated by the unfolded protein response. PLoS One 7(5):e36408
30. Liu H, Li M, Wang P, Wang F. 2011. Blockade of hypoxia-inducible factor-1alpha by YC-1 attenuates interferon-gamma and tumor necrosis factor-Alpha-induced intestinal epithelial barrier dysfunction. Cytokine 56(3):581-588
31. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. 2005. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: Role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 288(3): G422-G430
32. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM. 2004. TNF-Alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286(3): G367-G376
33. Nam SY, Ko YS, Jung J, Yoon J, Kim YH, Choi YJ, Park JW, Chang MS, Kim WH, Lee BL. 2011. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factorkappaB promotes gastric tumour growth and angiogenesis. Br J Cancer 104(1):166-174
34. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V. 2007. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 178(12):7516-7519
35. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, Collins JE. 2005. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85(9):1139-1162
36. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453(7196): 807-811
37. Rosenberger P, Khoury J, Kong T, Weissmuller T, Robinson AM, Colgan SP. 2007. Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J 21(10):2613-2621
38. Semenza GL. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13(2):167-171
39. Semenza GL. 2007. Life with oxygen. Science 318(5847):62-64
40. Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, Geboes K, Ceuppens JL, Rutgeerts P. 2002. Antitumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 97(8):2000-2004
41. Sun HL, Liu YN, Huang YT, Pan SL, Huang DY, Guh JH, Lee FY, Kuo SC, Teng CM. 2007. YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 26(27):3941-3951
42. Taylor CT. 2008. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol 586(Pt 17):4055-4059
43. Thapa RJ, Basagoudanavar SH, Nogusa S, Irrinki K, Mallilankaraman K, Slifker MJ, Beg AA, Madesh M, Balachandran S. 2011. NF-kappaB protects cells from gamma interferoninduced RIP1-dependent necroptosis. Mol Cell Biol 31(14): 2934-2946
44. Toiyama Y, Inoue Y, Saigusa S, Okugawa Y, Yokoe T, Tanaka K, Miki C, Kusunoki M. 2010. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery. Clin Oncol (R Coll Radiol) 22(4):272-280
45. Tsui L, Fong TH, Wang IJ. 2012. YC-1 targeting of hypoxiainducible factor-1alpha reduces RGC-5 cell viability and inhibits cell proliferation. Mol Vis 18:1594-1603
46. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141(5):769-776
47. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, Parkos CA, Nusrat A. 2005. Mechanism of IFN-gammainduced endocytosis of tight junction proteins: Myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16(10):5040-5052
48. van Uden P, Kenneth NS, Rocha S. 2008. Regulation of hypoxiainducible factor-1alpha by NF-kappaB. Biochem J 412(3):477-484
49. Ventura MT, Polimeno L, Amoruso AC, Gatti F, Annoscia E, Marinaro M, Di Leo E, Matino MG, Buquicchio R, Bonini S, Tursi A, Francavilla A. 2006. Intestinal permeability in patients with adverse reactions to food. Dig Liver Dis 38(10): 732-736
50. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. 2005. Interferon-gamma and tumor necrosis factoralpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166(2):409-419
51. Wells CL, van De Westerlo EM, Jechorek RP, Haines HM, Erlandsen SL. 1998. Cytochalasin-induced actin disruption of polarized enterocytes can augment internalization of bacteria. Infect Immun 66(6):2410-2419
52. Willemsen LE, Hoetjes JP, van Deventer SJ, van Tol EA. 2005. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition. Clin Exp Immunol 142(2):275-284
53. Wisner DM, Harris LR, 3rd, Green CL, Poritz LS. 2008. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4. J Surg Res 144(1):1-7
54. Yang H, Fan Y, Teitelbaum DH. 2003. Intraepithelial lymphocyte-derived interferon-gamma evokes enterocyte apoptosis with parenteral nutrition in mice. Am J Physiol Gastrointest Liver Physiol 284(4):G629-G637
55. Yang H, Kiristioglu I, Fan Y, Forbush B, Bishop DK, Antony PA, Zhou H, Teitelbaum DH. 2002. Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann Surg 236(2):226-234
56. Ye D, Ma I, Ma TY. 2006. Molecular mechanism of tumor necrosis factor-Alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 290(3):G496-G504
57. Yeh WL, Lu DY, Lin CJ, Liou HC, Fu WM. 2007. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol 72(2):440-449
58. Youakim A, Ahdieh M. 1999. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 276(5 Pt 1):G1279-G1288
59. Zhong LM, Zong Y, Sun L, Guo JZ, Zhang W, He Y, Song R, Wang WM, Xiao CJ, Lu D. 2012. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS One 7(2):e32195